. Cependant, la cause de décès est restée indéterminée pour un nombre non négligeable de patients

. Décès, 4% des décès) Pour cette raison, nous n'avons pas pratiqué d'analyse complémentaire sur la survie spécifique

. Tumeur-maligne, . Tissu-lymphatique-ou-hématopoïétique, and . Has, http://www.has-sante.fr/portail/upload/docs/application/pdf/2013- 10/guide_k_bronchopulmonaires_finalweb__091013.pdf. 5. National Lung Screening Trial Research Team et al. Reduced lung-cancer mortality with lowdose computed tomographic screening, N. Engl. J. Med, vol.365, pp.395-409, 2011.

N. Horeweg, Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers, The Lancet Oncology, vol.15, issue.12, pp.1342-1350, 2014.
DOI : 10.1016/S1470-2045(14)70387-0

F. Barlesi, Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), The Lancet, vol.387, issue.10026, pp.1415-1426, 2016.
DOI : 10.1016/S0140-6736(16)00004-0

C. Mascaux, The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis, British Journal of Cancer, vol.27, issue.Suppl 3, pp.131-139, 2005.
DOI : 10.1016/S0033-0620(85)80003-7

D. Meng, Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis, Lung Cancer, vol.81, issue.1, pp.1-10, 2013.
DOI : 10.1016/j.lungcan.2013.03.019

A. Hallqvist, Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy 11. Yagishita, S. et al. Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer, Lung Cancer Int. Cancer Sci, vol.2012, issue.106, pp.1-6, 2012.

D. J. Raz, Natural History of Stage I Non-Small Cell Lung Cancer, Chest, vol.132, issue.1, pp.193-199, 2007.
DOI : 10.1378/chest.06-3096

N. P. Rowell and C. J. Williams, Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review, ESMO Consensus Conference on Lung Cancer: early-stage nonsmall-cell lung cancer consensus on diagnosis, pp.628-638, 2001.

D. Palma, Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non???Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis, Journal of Clinical Oncology, vol.28, issue.35, pp.5153-5159, 2010.
DOI : 10.1200/JCO.2010.30.0731

S. S. Jeppesen, T. Schytte, H. R. Jensen, C. Brink, and O. Hansen, Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates, Acta Oncologica, vol.32, issue.7049, pp.1552-1558, 2013.
DOI : 10.1159/000324113

N. Bi, K. Shedden, X. Zheng, F. Kong, and . Spring, Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.95, issue.5, pp.1378-1390, 2016.
DOI : 10.1016/j.ijrobp.2016.04.016

A. Navarro-martin, Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months, Journal of Thoracic Oncology, vol.11, issue.7, pp.1101-1111, 2016.
DOI : 10.1016/j.jtho.2016.03.021

R. J. Ubels, Quality of life during 5 years after stereotactic radiotherapy in stage I nonsmall cell lung cancer 24. van der Voort van Zyp, N. C. et al. Quality of Life After Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer, 25. Nagata, Y. et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403, pp.31-37, 2010.

G. M. Videtic, A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927), International Journal of Radiation Oncology*Biology*Physics, vol.93, issue.4, pp.757-764, 2015.
DOI : 10.1016/j.ijrobp.2015.07.2260

R. Timmerman, Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer, JAMA, vol.303, issue.11
DOI : 10.1001/jama.2010.261

U. Ricardi, Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial, Lung Cancer, vol.68, issue.1, pp.72-77, 2010.
DOI : 10.1016/j.lungcan.2009.05.007

N. Kopek, Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer, Radiotherapy and Oncology, vol.93, issue.3, pp.402-407, 2006.
DOI : 10.1016/j.radonc.2009.06.002

P. Baumann, Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non???Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy, Journal of Clinical Oncology, vol.27, issue.20, pp.3290-3296, 2009.
DOI : 10.1200/JCO.2008.21.5681

P. Baumann, Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer ??? A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study, Radiotherapy and Oncology, vol.88, issue.3, pp.359-367, 2008.
DOI : 10.1016/j.radonc.2008.07.019

R. Timmerman, Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer, Journal of Clinical Oncology, vol.24, issue.30, pp.4833-4839, 2006.
DOI : 10.1200/JCO.2006.07.5937

M. A. Henderson, A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non???Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.789-795, 2010.
DOI : 10.1016/j.ijrobp.2009.02.051

M. Henderson, Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.2, pp.404-409, 2008.
DOI : 10.1016/j.ijrobp.2007.12.051

M. Koto, A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer, Radiotherapy and Oncology, vol.85, issue.3, pp.429-434, 2005.
DOI : 10.1016/j.radonc.2007.10.017

F. B. Zimmermann, Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC), Acta Oncologica, vol.106, issue.1, pp.796-801, 2006.
DOI : 10.1002/cncr.21747

J. R. Olsen, Dose???Response for Stereotactic Body Radiotherapy in Early-Stage Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.299-303, 2011.
DOI : 10.1016/j.ijrobp.2011.01.038

R. C. Mcgarry, L. Papiez, M. Williams, T. Whitford, and R. D. Timmerman, Stereotactic body radiation therapy of early-stage non???small-cell lung carcinoma: Phase I study, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.4, pp.1010-1015, 2005.
DOI : 10.1016/j.ijrobp.2005.03.073

R. Timmerman, Extracranial Stereotactic Radioablation *, Chest, vol.124, issue.5, pp.1946-1955, 2003.
DOI : 10.1378/chest.124.5.1946

H. Hof, Stereotactic single-dose radiotherapy of stage I non???small-cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.335-341, 2003.
DOI : 10.1016/S0360-3016(02)04504-2

M. Taremi, Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.967-973, 2012.
DOI : 10.1016/j.ijrobp.2010.12.039

J. Widder, D. Postmus, J. F. Ubbels, E. M. Wiegman, and J. A. Langendijk, Survival and Quality of Life After Stereotactic or 3D-Conformal Radiotherapy for Inoperable Early-Stage Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.291-297, 2011.
DOI : 10.1016/j.ijrobp.2011.03.052

S. Senthi, F. J. Lagerwaard, C. J. Haasbeek, B. J. Slotman, and S. Senan, Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis, The Lancet Oncology, vol.13, issue.8, pp.802-809, 2012.
DOI : 10.1016/S1470-2045(12)70242-5

M. Guckenberger, Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis, Journal of Thoracic Oncology, vol.8, issue.8, pp.1050-1058, 2013.
DOI : 10.1097/JTO.0b013e318293dc45

M. Guckenberger, Dose???Response Relationship for Image-Guided Stereotactic Body Radiotherapy of Pulmonary Tumors: Relevance of 4D Dose Calculation, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.1, pp.47-54, 2009.
DOI : 10.1016/j.ijrobp.2008.06.1939

J. N. Davis, Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry, Journal of Radiation Oncology, vol.52, issue.7, pp.55-63, 2015.
DOI : 10.3109/0284186X.2013.813635

R. J. Klement, Prediction of Early Death in Patients with Early-Stage NSCLC???Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?, Journal of Thoracic Oncology, vol.11, issue.7
DOI : 10.1016/j.jtho.2016.03.016

L. Kestin, Dose???response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance, Radiotherapy and Oncology, vol.110, issue.3, pp.499-504, 2014.
DOI : 10.1016/j.radonc.2014.02.002

I. S. Grills, A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non???Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy, Journal of Thoracic Oncology, vol.7, issue.9, pp.1382-1393, 2012.
DOI : 10.1097/JTO.0b013e318260e00d

U. Ricardi, Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study, Lung Cancer, vol.84, issue.3, pp.248-253, 2014.
DOI : 10.1016/j.lungcan.2014.02.015

P. Baumann, Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries, Acta Oncologica, vol.53, issue.3, pp.787-795, 2006.
DOI : 10.1055/s-2005-837631

Y. Tsurugai, T. Kozuka, N. Ishizuka, and M. Oguchi, Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer, Lung Cancer, vol.92, pp.47-52, 2016.
DOI : 10.1016/j.lungcan.2015.12.003

D. E. Spratt, Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non???Small-Cell Lung Cancer: Implications for Surveillance, Clinical Lung Cancer, vol.17, issue.3, pp.177-183, 2016.
DOI : 10.1016/j.cllc.2015.09.006

N. Shaverdian, Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non???Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy, Clinical Lung Cancer, vol.17, issue.1, pp.39-46, 2016.
DOI : 10.1016/j.cllc.2015.07.007

J. Bibault, Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients, PLOS ONE, vol.81, issue.7, p.133617, 2015.
DOI : 10.1371/journal.pone.0133617.t003

Z. A. Kohutek, FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer, Lung Cancer, vol.89, issue.2, pp.115-120, 2015.
DOI : 10.1016/j.lungcan.2015.05.019

Y. Shibamoto, Stereotactic Body Radiotherapy Using a Radiobiology-Based Regimen for Stage I Non???Small-Cell Lung Cancer: Five-Year Mature Results, Journal of Thoracic Oncology, vol.10, issue.6, pp.960-964, 2015.
DOI : 10.1097/JTO.0000000000000525

Y. Shibamoto, Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer, Cancer, vol.79, issue.suppl, pp.2078-2084, 2012.
DOI : 10.1080/09553000310001609224

F. Baba, Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size, Radiation Oncology, vol.5, issue.1, p.1, 2010.
DOI : 10.1186/1748-717X-5-81

H. Bahig, Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis, Technology in Cancer Research & Treatment, vol.14, issue.6, pp.667-676, 2015.
DOI : 10.7785/tcrt.2012.500445

M. Hamaji, Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.11
DOI : 10.1097/JTO.0000000000000662

Y. Matsuo, Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis, European Journal of Cancer, vol.50, issue.17, pp.2932-2938, 1990.
DOI : 10.1016/j.ejca.2014.09.006

Y. Matsuo, Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac, Radiotherapy and Oncology, vol.112, issue.3, pp.360-364, 2014.
DOI : 10.1016/j.radonc.2014.08.003

N. E. Verstegen, Patterns of Disease Recurrence after SABR for Early Stage

F. J. Lagerwaard, Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.7, issue.7, pp.1148-1154, 2012.
DOI : 10.1097/JTO.0b013e318252cfef

E. M. Bongers, C. J. Haasbeek, F. J. Lagerwaard, B. J. Slotman, and S. Senan, Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.6, issue.12, pp.2052-2057, 2011.
DOI : 10.1097/JTO.0b013e3182307e74

F. J. Lagerwaard, C. J. Haasbeek, E. F. Smit, B. J. Slotman, and S. Senan, Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.3, pp.685-692, 2008.
DOI : 10.1016/j.ijrobp.2007.10.053

G. Marwaha, K. L. Stephans, N. M. Woody, C. A. Reddy, and G. M. Videtic, Lung Stereotactic Body Radiation Therapy: Regional Nodal Failure Is Not Predicted by Tumor Size, Journal of Thoracic Oncology, vol.9, issue.11, pp.1693-1697, 2014.
DOI : 10.1097/JTO.0000000000000313

URL : https://doi.org/10.1097/jto.0000000000000313

J. Y. Chang, Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a ???No Fly Zone???, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5
DOI : 10.1016/j.ijrobp.2014.01.022

J. Y. Chang, Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer, Cancer, vol.104, issue.18, pp.3402-3410, 2013.
DOI : 10.1016/j.radonc.2012.01.014

J. Y. Chang, Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer, Radiation Oncology, vol.7, issue.1, 2012.
DOI : 10.1016/j.radonc.2010.04.011

S. S. Jeppesen, T. Schytte, H. R. Jensen, C. Brink, and O. Hansen, Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates, Acta Oncologica, vol.32, issue.7049, pp.1552-1558, 2013.
DOI : 10.1159/000324113

T. Inoue, Stereotactic body radiotherapy using gated radiotherapy with real-time tumortracking for stage I non-small cell lung cancer, Radiat. Oncol, vol.8, p.1, 2013.

A. Takeda, Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer, Lung Cancer, vol.77, issue.1, pp.77-82, 2012.
DOI : 10.1016/j.lungcan.2012.01.006

A. Takeda, Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer, Lung Cancer, vol.79, issue.3, pp.248-253, 2013.
DOI : 10.1016/j.lungcan.2012.11.008

A. Takeda, Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.2, pp.257-263, 2013.
DOI : 10.1016/j.ijrobp.2013.01.006

A. Takeda, Stereotactic Body Radiotherapy for Primary Lung Cancer at a Dose of 50 Gy Total in Five Fractions to the Periphery of the Planning Target Volume Calculated Using a Superposition Algorithm, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.2, pp.442-448, 2009.
DOI : 10.1016/j.ijrobp.2008.04.043

V. R. Bollineni, J. Widder, J. Pruim, J. A. Langendijk, and E. M. Wiegman, Residual 18F-FDG-PET Uptake 12 Weeks After Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Predicts Local Control, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.4, pp.551-555, 2012.
DOI : 10.1016/j.ijrobp.2012.01.012

J. Y. Chang, Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials, The Lancet Oncology, vol.16, issue.6, pp.630-637, 2010.
DOI : 10.1016/S1470-2045(15)70168-3

N. Mohammed, Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors, Radiotherapy and Oncology, vol.99, issue.1, pp.18-22, 2011.
DOI : 10.1016/j.radonc.2011.03.003

J. Wang, Z. Zuo, H. Zhang, W. Li, and K. Wang, Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC], Zhongguo Fei Ai Za Zhi Chin. J. Lung Cancer, vol.19, pp.136-146, 2016.

X. Zheng, Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.90, issue.3, pp.603-611, 2014.
DOI : 10.1016/j.ijrobp.2014.05.055

J. E. Rosen, Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.152, issue.1, pp.44-54, 2016.
DOI : 10.1016/j.jtcvs.2016.03.060

V. Puri, Treatment Outcomes in Stage I Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.12, pp.1776-1784, 2015.
DOI : 10.1097/JTO.0000000000000680

H. Liu, Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta ??? A population-based study, Radiotherapy and Oncology, vol.117, issue.1, pp.71-76, 2015.
DOI : 10.1016/j.radonc.2015.08.027

J. B. Yu, Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer, Cancer, vol.23, issue.14, pp.2341-2349, 2015.
DOI : 10.1016/S0272-5231(03)00063-7

N. Ezer, Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.8, pp.1201-1206, 2015.
DOI : 10.1097/JTO.0000000000000600

S. M. Shirvani, Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non???Small Cell Lung Cancers in the Elderly, JAMA Surgery, vol.149, issue.12, p.1244, 2014.
DOI : 10.1001/jamasurg.2014.556

D. Palma, Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery, Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir. Investig, pp.240-244, 2011.
DOI : 10.1016/j.radonc.2011.06.029

L. L. Van-den-berg, T. J. Klinkenberg, H. J. Groen, and J. Widder, Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC, Journal of Thoracic Oncology, vol.10, issue.5, pp.826-831, 2015.
DOI : 10.1097/JTO.0000000000000483

S. Mokhles, Survival and Treatment of Non-small Cell Lung Cancer Stage I???II Treated Surgically or with Stereotactic Body Radiotherapy: Patient and Tumor-Specific Factors Affect the Prognosis, Annals of Surgical Oncology, vol.144, issue.5, pp.316-323, 2015.
DOI : 10.1016/j.cell.2011.02.013

M. Hamaji, Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer, The Annals of Thoracic Surgery, vol.99, issue.4, pp.1122-1129, 2015.
DOI : 10.1016/j.athoracsur.2014.11.009

N. E. Verstegen, Stage I???II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis, Annals of Oncology, vol.24, issue.6, pp.1543-1548, 2013.
DOI : 10.1093/annonc/mdt026

C. G. Robinson, Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non???Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.8, issue.2, pp.192-201, 2013.
DOI : 10.1097/JTO.0b013e31827ce361

V. Puri, A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis, The Journal of Thoracic and Cardiovascular Surgery, vol.143, issue.2, pp.428-436, 2012.
DOI : 10.1016/j.jtcvs.2011.10.078

T. D. Crabtree, Stereotactic body radiation therapy versus surgical resection for stage I non???small cell lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.140, issue.2, pp.377-386, 2010.
DOI : 10.1016/j.jtcvs.2009.12.054

M. A. Tucker, Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer, JNCI Journal of the National Cancer Institute, vol.89, issue.23, pp.1782-1788, 1997.
DOI : 10.1093/jnci/89.23.1782

M. Reck, Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.25, issue.suppl 3
DOI : 10.1093/annonc/mdu199

K. M. Creach, J. D. Bradley, P. Mahasittiwat, and C. G. Robinson, Stereotactic body radiation therapy in the treatment of multiple primary lung cancers, Radiotherapy and Oncology, vol.104, issue.1, pp.19-22, 2012.
DOI : 10.1016/j.radonc.2011.12.005

G. H. Griffioen, Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery, Radiotherapy and Oncology, vol.107, issue.3, pp.403-408, 2013.
DOI : 10.1016/j.radonc.2013.04.026

A. A. Loukeri, C. F. Kampolis, A. Ntokou, G. Tsoukalas, and K. Syrigos, Metachronous and Synchronous Primary Lung Cancers: Diagnostic Aspects, Surgical Treatment, and Prognosis, Clinical Lung Cancer, vol.16, issue.1, pp.15-23, 2015.
DOI : 10.1016/j.cllc.2014.07.001

A. Ashworth, G. Rodrigues, G. Boldt, and D. Palma, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, vol.82, issue.2, pp.197-203, 2013.
DOI : 10.1016/j.lungcan.2013.07.026

K. S. Corbin, S. Hellman, and R. R. Weichselbaum, Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy, Journal of Clinical Oncology, vol.31, issue.11, pp.1384-1390, 2013.
DOI : 10.1200/JCO.2012.45.9651

H. Yamashita, Lung stereotactic radiotherapy for oligometastases: comparison of oligorecurrence and sync-oligometastases. Jpn, J. Clin. Oncol, 2016.

W. Takahashi, Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases, Pulmonary Medicine, vol.28, issue.6, pp.1-5, 2012.
DOI : 10.1016/j.radonc.2012.01.011

U. Pastorino, Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases, The Journal of Thoracic and Cardiovascular Surgery, vol.113, issue.1, pp.37-49, 1997.
DOI : 10.1016/S0022-5223(97)70397-0

J. K. Salama, Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, vol.366, issue.3 suppl, pp.2962-2970, 2012.
DOI : 10.1016/S0140-6736(05)66954-1

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.26611/pdf

A. A. Solanki, The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study, Radiation Oncology, vol.7, issue.1, 2012.
DOI : 10.1016/j.lungcan.2006.12.009

M. T. Lee, Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1585-1591, 2009.
DOI : 10.1200/JCO.2008.20.0600

X. S. Wang, Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1???2 trial, The Lancet Oncology, vol.13, issue.4, pp.395-402, 2012.
DOI : 10.1016/S1470-2045(11)70384-9

A. K. Garg, Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases, Cancer, vol.70, issue.22 suppl, pp.5069-5077, 2012.
DOI : 10.1016/j.ijrobp.2007.10.059

K. E. Rusthoven, Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1572-1578, 2009.
DOI : 10.1200/JCO.2008.19.6329

B. D. Kavanagh, Interim analysis of a prospective phase I/II trial of SBRT for liver metastases, Acta Oncologica, vol.76, issue.7, pp.848-855, 2006.
DOI : 10.1007/s00104-005-1039-5

K. E. Rusthoven, Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1579-1584, 2009.
DOI : 10.1200/JCO.2008.19.6386

P. Okunieff, Stereotactic Body Radiation Therapy (SBRT) for lung metastases, Acta Oncologica, vol.57, issue.7, pp.808-817, 2006.
DOI : 10.1016/S0360-3016(03)00846-0

P. Navarria, Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments, Radiation Oncology, vol.9, issue.1, p.1, 2014.
DOI : 10.1097/JTO.0b013e31824166a5

M. T. Milano, A. W. Katz, H. Zhang, and P. Okunieff, Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.878-886, 2012.
DOI : 10.1016/j.ijrobp.2011.08.036

M. T. Milano, H. Zhang, S. K. Metcalfe, A. G. Muhs, and P. Okunieff, Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy, Breast Cancer Research and Treatment, vol.104, issue.3, pp.601-608, 2009.
DOI : 10.1016/j.ijrobp.2006.10.025

M. T. Milano, A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions, Cancer, vol.64, issue.3, pp.650-658, 2008.
DOI : 10.1016/j.ijrobp.2006.10.025

C. Collen, Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients, Annals of Oncology, vol.25, issue.10, pp.1954-1959, 2014.
DOI : 10.1093/annonc/mdu370

D. A. Palma, Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial, BMC Cancer, vol.16, issue.2, p.305, 2012.
DOI : 10.1016/j.semradonc.2005.12.002

S. H. Lim, A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer, Annals of Oncology, vol.26, issue.4
DOI : 10.1093/annonc/mdu584

S. H. Lim, A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer, Annals of Oncology, vol.26, issue.4
DOI : 10.1093/annonc/mdu584

D. De-ruysscher, Radical Treatment of Non???Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450), Journal of Thoracic Oncology, vol.7, issue.10, pp.1547-1555, 2012.
DOI : 10.1097/JTO.0b013e318262caf6

C. Collen, Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients, Annals of Oncology, vol.25, issue.10, pp.1954-1959, 2014.
DOI : 10.1093/annonc/mdu370

A. B. Ashworth, An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.15, issue.5, pp.346-355, 2014.
DOI : 10.1016/j.cllc.2014.04.003

A. Ashworth, G. Rodrigues, G. Boldt, and D. Palma, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, vol.82, issue.2, pp.197-203, 2013.
DOI : 10.1016/j.lungcan.2013.07.026

J. Zhang, Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer? A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.305-316, 2011.
DOI : 10.1016/j.ijrobp.2011.04.034

M. Koshy, R. Malik, R. R. Weichselbaum, and D. J. Sher, Increasing Radiation Therapy Dose Is Associated With Improved Survival in Patients Undergoing Stereotactic Body Radiation Therapy for Stage I??Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.91, issue.2, pp.344-350, 2015.
DOI : 10.1016/j.ijrobp.2014.10.002

H. Onishi, Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study, Journal of Thoracic Oncology, vol.2, issue.7, pp.94-100, 2007.
DOI : 10.1097/JTO.0b013e318074de34

N. Mehta, Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control, Practical Radiation Oncology, vol.2, issue.4, pp.288-295, 2012.
DOI : 10.1016/j.prro.2011.10.004

M. Kim, Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery, Radiation Oncology Journal, vol.33, issue.4, p.265, 2015.
DOI : 10.3857/roj.2015.33.4.265

Z. Allibhai, The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.87, issue.5, pp.1064-1070, 2013.
DOI : 10.1016/j.ijrobp.2013.08.020

P. Baumann, Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries, Acta Oncologica, vol.53, issue.3, pp.787-795, 2006.
DOI : 10.1055/s-2005-837631

F. Na, Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non???Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis, Journal of Thoracic Oncology, vol.9, issue.6, pp.834-842, 2014.
DOI : 10.1097/JTO.0000000000000185

M. Paesmans, Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.5, issue.5
DOI : 10.1097/JTO.0b013e3181d0a4f5

T. Berghmans, Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.3, issue.1, pp.6-12, 2008.
DOI : 10.1097/JTO.0b013e31815e6d6b

J. Liu, Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis, PLOS ONE, vol.31, issue.30, p.146195, 2016.
DOI : 10.1371/journal.pone.0146195.s002

H. Im, Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.285, issue.7, pp.241-251, 2015.
DOI : 10.1097/MNM.0b013e3283599999

Y. Satoh, H. Onishi, A. Nambu, and T. Araki, Volume-based Parameters Measured by Using FDG PET/CT in Patients with Stage I NSCLC Treated with Stereotactic Body Radiation Therapy: Prognostic Value, Radiology, vol.270, issue.1, pp.275-281, 2014.
DOI : 10.1148/radiol.13130652

Y. Shioyama, Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience, Journal of Radiation Research, vol.54, issue.1, pp.108-112, 2013.
DOI : 10.1093/jrr/rrs075

G. M. Videtic, Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer, Practical Radiation Oncology, vol.3, issue.4, pp.301-306, 2013.
DOI : 10.1016/j.prro.2012.10.003

N. B. Ly, Stereotactic body radiation therapy for stage I small cell lung cancer: a single institutional case series and review of the literature, Journal of Radiation Oncology, vol.24, issue.7, pp.285-291, 2014.
DOI : 10.1097/JTO.0b013e3181cd3208

Y. Shioyama, Multi-institutional Retrospective Study of Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer: Japan Radiation Oncology Study Group (JROSG), International Journal of Radiation Oncology*Biology*Physics, vol.93, issue.3, p.101, 2015.
DOI : 10.1016/j.ijrobp.2015.07.243

C. Li, Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study, Medical Oncology, vol.102, issue.30, p.369, 2014.
DOI : 10.1016/j.radonc.2011.12.023

C. Li, Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study, Medical Oncology, vol.102, issue.30, p.31, 2014.
DOI : 10.1016/j.radonc.2011.12.023

Y. Shioyama, Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience, Journal of Radiation Research, vol.54, issue.1, pp.108-112, 2013.
DOI : 10.1093/jrr/rrs075

R. H. Mak, Outcomes by Tumor Histology and KRAS Mutation Status After Lung Stereotactic Body??Radiation Therapy for Early-Stage Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.16, issue.1, pp.24-32, 2015.
DOI : 10.1016/j.cllc.2014.09.005